µ¼Ê¦ÐÕÃû£ºÖܾ²
ÐÔ±ð£ºÅ®
ÈËÆøÖ¸Êý£º363
ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧ
ËùÊôԺϵ£º¹ú¼ÒÉúÎï°ÐÏòÕïÖιú¼ÊÁªºÏÖÐÐÄ¡¢»ù´¡Ò½Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÉúÀíѧ¡¢Ò½Ñ§ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ¡¢Ò½Ñ§ÉúÀíѧ
Ñо¿ÁìÓò£º 1.Ö×ÁöµÄ·¢²¡»úÀíÒÔ¼°Ö²ÎïÒ©µÄ¿¹°©»úÀíÑо¿2.´úл¼²²¡£¨·ÊÅÖÒÔ¼°ÌÇÄò²¡£©µÄ·¢²¡»úÀí£¬ÒÔ¼°Óª... [Õ¹¿ª]
Ñо¿ÁìÓò£º 1.Ö×ÁöµÄ·¢²¡»úÀíÒÔ¼°Ö²ÎïÒ©µÄ¿¹°©»úÀíÑо¿2.´úл¼²²¡£¨·ÊÅÖÒÔ¼°ÌÇÄò²¡£©µÄ·¢²¡»úÀí£¬ÒÔ¼°ÓªÑø¡¢ÒûʳÓÚÆäÖеĸÉÔ¤ÖÎÁƼÛÖµ3.ϸ°ûµòÍöºÍ×ÔÊÉ×÷Óõĵ÷¿Ø»úÖÆ [ÊÕÆð]
¸öÈ˼òÊö :
Öܾ²£¬Å®£¬²©Ê¿£¬ÓÚ2010Äê±ÏÒµÓÚÐÂ¼ÓÆÂ¹úÁ¢´óѧҽѧԺ£¬»ñµÃϸ°û·Ö×ÓÉúÎïѧ²©Ê¿Ñ§Î»£¬ËæºóÎåÄêÏȺó¾ÍÖ°ÓÚÐÂ¼ÓÆÂ¹úÁ¢´óѧÒÔ¼°ÄÏÑóÀí¹¤´óѧ£¬½øÐв©Ê¿ºóÅàѵ¡£ÒÔµÚÒ»×÷Õߺ͹²Í¬×÷ÕßÓÚCell?Research£¬Autophagy£¬Hepatology£¬Molecular?Cancer?TherapeuticsÒÔ¼°Biological?PharmacologyµÈ¸ßˮƽ¹ú¼ÊÆÚ¿¯ÉÏ·¢±íSCIÂÛÎÄ20ƪ¡£ÔÚ´ÓÊ¿ÆÑй¤×÷µÄ12Äê¼ä£¬½¨Á¢ÁË×ÔÊÉ-ÈÜøÌåµ÷¿Ø»úÖÆ¡¢Ö²ÎïÒ©µ÷¿ØµòÍöÒÔ¼°×ÔÊɵĿ¹°©»úÀí¡¢×ÔÊÉÓëÖ¬Àà´úлµÈÑо¿Æ½Ì¨¡£2014Äêͨ¹ý¹ãÎ÷¸ßУ¡°°ÙÈ˼ƻ®¡±È˲ÅÒý½ø»Ø¹ú£¬¿ªÕ¹¿ÆÑнÌѧ¹¤×÷¡£Ä¿Ç°¾ÍÖ°ÓÚ¹ãÎ÷Ò½¿Æ´óѧ»ù´¡Ò½Ñ§Ñ§ÔºÉúÀí½ÌÑÐÊÒ£¬µ£ÈÎÉúÀíѧ¡¢ÊµÑéÉúÀíѧµÄ½Ìѧ¹¤×÷£»Ö÷³Ö¹ãÎ÷¸ßУ¡°°ÙÈ˼ƻ®¡±×¨Ïî¿ÎÌâ,¹ú¼Ò×ÔÈ»»ù½ðÏîÄ¿ÒÔ¼°¹ãÎ÷×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¹²ÈýÏî¡£¾ßÓÐ14ÄêÖÐÎ÷Ò½½áºÏ»ù´¡Ò½Ñ§ÒÔ¼°Ó¦ÓÃϸ°û·Ö×ÓÉúÎïµÄ¿ÆÑоÑ飬ʵÑéË®Æ½È«Ãæ£¬¾ß±¸¶ÀÁ¢¹¤×÷ÒÔ¼°Áìµ¼ÄÜÁ¦£¬ÖØÊÓÍŶӺÏ×÷¾«Éñ£¬ÉÆÓÚе÷¹µÍ¨¡£Á¼ºÃµÄÖÐÓ¢ÎÄÊéд¡¢Ñݽ²½»Á÷ÄÜÁ¦¡£
¿ÆÑй¤×÷ :
ÒÑ·¢±íµÄ´ú±íÐÔÂÛÎÄ£º[1]?Zhou?J#,Tang?Y,Xie?ZJ,Lu?JN,Deng?JH,Huang?XW,Chuan?Hooi?S,He?M,Lu?GD£ª.?AKT?activation?was?not?essential?for?hepatocellular?carcinoma?cell?survival?under?glucose?deprivation.?Anticancer?Drugs.2017?Apr28(4):427-435.?£¨IF?2.268£©[2]?Shi?Y#,?Tan?SH,?Ng?S,?Zhou?J,?Yang?ND,?Koo?GB,?Mcmahon?KA,?Parton?RG,?Hill?MM,?Del?PozoMA,?Kim?YS,?Shen?HM£ª.?Critical?role?of?CAV1/caveolin-1?in?cell?stress?responses?in?human?breast?cancer?cells?via?modulation?of?lysosomal?function?and?autophagy.?Autophagy.?2015?11(5):769-84.?£¨IF?9.108£©[3]?Zhang?J#,?Ng?S,?Wang?J,?Zhou?J,?Tan?SH,?Yang?N,?Lin?Q,?Xia?D,?Shen?HM£ª.?Histone?deacetylase?inhibitors?induce?autophagy?through?FOXO1-dependent?pathways.?Autophagy.?2015?Apr?311(4):629-42.?£¨IF?9.108£©[4]?Lu?GD£ª#,?Ang?YH,?Zhou?J,?Tamilarasi?J,?Yan?B,?Lim?YC,?Srivastava?S,?Salto-Tellez?M,?Hui?KM,?Shen?HM,?Nguyen?LN,?Tan?BC,?Silver?DL,?Hooi?SC£ª.?C/EBPalpha?predicts?poorer?prognosis?and?prevents?energy?starvation-induced?cell?death?in?hepatocellular?carcinoma.?Hepatology.?2015?61(3):?965-78.£¨IF?11.711£©[5]?Yang?ND,?Tan?SH,?Ng?S,?Shi?Y,?Zhou?J,?Tan?KS,?Wong?WS,?Shen?HM.?Artesunate?induces?cell?death?in?human?cancer?cells?via?enhancing?lysosomal?function?and?lysosomal?degradation?of?ferritin.?J?Biol?Chem.?2014?Nov?28289(48):33425-41.[6]?Tan?SH#,?Shui?G,?Zhou?J,?Shi?Y,?Huang?J,?Xia?D,?Wenk?MR,?Shen?HM£ª.?Critical?role?of?SCD1?in?autophagy?regulation?via?lipogenesis?and?lipid?rafts-coupled?AKT-FOXO1?signaling?pathway.?Autophagy.?2014?Feb10(2):226-42.£¨IF?9.108£©[7]?Wang?J#,?Tan?XF.,?Nguyen?VS,?Yang?P,?Zhou?J,?Gao?M,?Li?Z,?Lim?TK.,?He?Y,?Ong?CS,?Zhang?J,?Zhu?G,?Lai?SL,?Ghosh?D,?Mok?YK,?Shen?HM,?Lin?Q£ª.?(2014).?A?quantitative?chemical?proteomics?approach?to?profile?the?specific?cellular?targets?of?andrographolide,?a?promising?anticancer?agent?that?suppresses?tumor?metastasis.?Mol?Cell?Proteomics?13,?876-886.?(IF?6.5641)[8]?Zhou?J#,?Tan,?SH,?Codogno?P,?and?Shen?HM£ª.?Dual?suppressive?effect?of?mTORC1?on?autophagy:?tame?the?dragon?by?shackling?both?the?head?and?the?tail.?Autophagy?2013.?2013?May9(5):803-5.?£¨IF?9.108£©[9]?Zhou?J#,?Tan?SH,?Nicolas?V,?Bauvy?C,?Yang?ND,?Zhang?J,?Xue?Y,?Codogno?P,?Shen?HM£ª.?Activation?of?lysosomal?function?in?the?course?of?autophagy?via?mTORC1?suppression?and?autophagosome-lysosome?fusion.?Cell?Res?2013?Apr23(4):508-23.?£¨IF?14.812£©[10]?Zhou?J#,?Ng?S,?Huang?Q,?Wu?YT,?Li?Z,?Yao?SQ,?Shen?HM£ª.?AMPK?mediates?a?pro-survival?autophagy?downstream?of?PARP-1?activation?in?response?to?DNA?alkylating?agents.?FEBS?Lett.?16587(2):170-7,?2013.?£¨IF?3.519£©[11]?Tan?SH#,?Shui?G,?Zhou?J,?Li?JJ,?Bay?BH.,?Wenk?MR.,?and?Shen?HM£ª.?Induction?of?autophagy?by?palmitic?acid?via?protein?kinase?C-mediated?signaling?pathway?independent?of?mTOR?(mammalian?target?of?rapamycin).?J?Biol?Chem?287,?14364-14376,?2012.?£¨IF?4.258£©[12]?Zhang?Y#,?Yang?ND,?Zhou?F,?Shen?T,?Duan?T,?Zhou?J,?Shi?Y,?Zhu?XQ,?Shen?HM£ª.?(-)-Epigallocatechin-3-gallate?induces?non-apoptotic?cell?death?in?human?cancer?cells?via?ROS-mediated?lysosomal?membrane?permeabilization.?PLoS?One.?7(10):e46749,?2012.?(IF??3.730)[13]?Zhou?J1#,?Hu?SE1#,?Tan?SH,?Cao?R,?Chen?Y,?Xia?D,?Zhu?X,?Yang?XF,?Ong?CN,?Shen?HM£ª.?Andrographolide?sensitizes?cisplatin-induced?apoptosis?via?suppression?of?autophagosome-lysosome?fusion?in?human?cancer?cells.?Autophagy?8:?338-349,?2012.?£¨IF?9.108£©*¹²Í¬µÚÒ»×÷Õß[14]?Ng?SK,?Chen?B,?Wu?YT,?Zhou?J,?Shen?HM.?Constitutive?mTOR?activation?suppresses?autophagy?and?sensitizes?TSC2-null?cells?to?cell?death.?Autophagy?7:1173-86,?2011.[15]?Zhou?J,?Ong?CN,?Hur?GM,?Shen?HM.?Inhibition?of?the?JAK-STAT3?pathway?by?andrographolide?enhances?chemosensitivity?of?cancer?cells?to?doxorubicin.?Biochem?Pharmacol?79(9):1242-50?2010.?£¨IF?5.091£©[16]??Ong?CS,?Zhou?J,?Ong?CN,?Shen?HM.?Luteolin?induces?G1?arrest?in?human?nasopharyngeal?carcinoma?cells?via?the?Akt-GSK-3?beta-Cyclin?D1?pathway.?Cancer?Letters?298(2):?167-75?2010.?(IF?4.248)[17]?Zhou?J,?Lu?GD,?Ong?CS,?Ong?CN,?Shen?HM.?Andrographolide?sensitizes?cancer?cells?to?TRAIL-induced?apoptosis?via?p53-mediated?death?receptor?4?up-regulation.?Mol?Cancer?Ther??7(7):?2170-80.?£¨IF?5.579£©[18]?Zhou?J,?Zhang?S,?Ong?CN,?Shen?HM.?Critical?role?of?pro-apoptotic?Bcl-2?family?members?in?andrographolide-induced?apoptosis?inhuman?cancer?cells.?Biochem?Pharmacol?72:132-144?2006.?£¨IF?5.091£©[19]?Zhou?J,?Xiao?C,?Zhao?L,Jia?H,?Zhao?N,?Lu?C,?Yang?D,?Tang?JC,?Chan?AS,?Lu?AP.?The?effect?of?triptolide?on?CD4+?and?CD8+?cells?in?Peyer's?patch?of?SD?rats?with?collagen?induced?arthritis.?Int?Immunopharmacol?6(2):198-203?2006.?£¨IF?2.551£©¡£
¹ãÎ÷Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Öܾ²
±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø/2019-05-27
Ïà¹Ø»°Ìâ/ÉúÀíѧ ϸ°û Ö²Îï ¹ãÎ÷ ¼²²¡
¹ãÎ÷Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-лӨ
µ¼Ê¦ÐÕÃû£ºÐ»Ó¨ÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º352ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧËùÊôԺϵ£ºÉúÃü¿ÆÑ§Ñо¿Ôº¡¢Ö×ÁöҽѧԺְ³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÖ×Áöѧ¡¢ÉúÎïҽѧ¹¤³ÌÑо¿ÁìÓò£º±ÇÑʰ©ÔçÆÚ·ÀÖμ°Áܰͽá×ªÒÆ»úÖÆÑо¿Ñо¿ÁìÓò£º±ÇÑʰ©ÔçÆÚ·ÀÖμ°Áܰͽá×ªÒÆ»úÖÆÑо¿[ÊÕÆð]¸öÈ˼òÊö:лӨ£¬1978Äê11ÔÂÉú£¬½ÌÊÚ£¬¶ú±ÇÑÊºí¿ÆÑ§ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27¹ãÎ÷Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÕŽ£·æ
µ¼Ê¦ÐÕÃû£ºÕŽ£·æÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º348ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧËùÊôԺϵ£ºµÚ¶þÁÙ´²Ò½Ñ§ÔºÖ°³Æ£ºÖ÷ÈÎҽʦµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º¼±Õïҽѧ¡¢È«¿ÆÒ½Ñ§¡¢¼±Õïҽѧ(öλÔÓéÀֵǼÈë¿ÚÏÂÔØÐÍ)¡¢È«¿ÆÒ½Ñ§(öλÔÓéÀֵǼÈë¿ÚÏÂÔØÐÍ)Ñо¿ÁìÓò£º¼±ÐÔ·ÎËðÉË¡¢ÉöËðÉË·ÀÖΣ»¼±Î£ÖØÖ¢¾ÈÖΣ»È«¿ÆÁÙ´²Êµ¼ù¡£Ñо¿ÁìÓò£º¼±ÐÔ·ÎËðÉË¡¢ÉöËðÉË·ÀÖΣ»¼±Î£ÖØÖ¢¾ÈÖΣ»È«¿ÆÁÙ´² ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27¹ãÎ÷Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Îâ¿¡¶Ë
µ¼Ê¦ÐÕÃû£ºÎâ¿¡¶ËÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º336ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧËùÊôԺϵ£º¹«¹²ÎÀÉúѧԺְ³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º¶ùÉÙÎÀÉúÓ븾Ó×±£½¡Ñ§¡¢Ò½Ñ§ÐÄÀíѧÑо¿ÁìÓò£ºÐÄÀíÓ¦¼¤¡¢ÁÙ´²ÐÄÀíѧ¡¢ÐÄÀí½¡¿µ½ÌÓýÓë´Ù½øµÈ¡£Ñо¿ÁìÓò£ºÐÄÀíÓ¦¼¤¡¢ÁÙ´²ÐÄÀíѧ¡¢ÐÄÀí½¡¿µ½ÌÓýÓë´Ù½øµÈ¡£[ÊÕÆð]¸öÈ˼òÊö:Îâ¿¡¶Ë£¬Å®£¬²©Ê¿£¬½ÌÊÚ£¬ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27¹ãÎ÷Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-»ÆÑ©
µ¼Ê¦ÐÕÃû£º»ÆÑ©ÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º336ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ò½Ñ§ÔºÖ°³Æ£ºÖ÷ÈÎҽʦµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÄÚ¿ÆÑ§¡¢ÀÏÄêҽѧ¡¢ÄÚ¿ÆÑ§(öλÔÓéÀֵǼÈë¿ÚÏÂÔØÐÍ)Ñо¿ÁìÓò£ºÓÄÃÅÂݸ˾ú¸ÐȾÓëÏû»¯ÏµÍ³¼²²¡£»Ñ×Ö¢ÐÔ³¦²¡µÄ»ù´¡ÓëÁÙ´²Ñо¿Ñо¿ÁìÓò£ºÓÄÃÅÂݸ˾ú¸ÐȾÓëÏû»¯ÏµÍ³¼²²¡£»Ñ×Ö¢ÐÔ³¦²¡µÄ»ù´¡ÓëÁÙ´²Ñо¿[ÊÕÆð]¸öÈË ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27¹ãÎ÷Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÕÔ»áÃñ
µ¼Ê¦ÐÕÃû£ºÕÔ»áÃñÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º332ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧËùÊôԺϵ£ºµÚ¶þÁÙ´²Ò½Ñ§ÔºÖ°³Æ£ºÖ÷ÈÎҽʦµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º¼±Õïҽѧ¡¢È«¿ÆÒ½Ñ§¡¢¼±Õïҽѧ(öλÔÓéÀֵǼÈë¿ÚÏÂÔØÐÍ)¡¢È«¿ÆÒ½Ñ§(öλÔÓéÀֵǼÈë¿ÚÏÂÔØÐÍ)Ñо¿ÁìÓò£º´´É˾ÈÖλù´¡ÓëÁÙ´²£¬Ðݿ˸´ËÕ¡£Ñо¿ÁìÓò£º´´É˾ÈÖλù´¡ÓëÁÙ´²£¬Ðݿ˸´ËÕ¡£[ÊÕÆð]¸öÈ˼òÊö:ÕÔ»áÃñ£¬Ò½Ñ§²©Ê¿£¬¹ã ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27¹ãÎ÷Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Ñô½à
µ¼Ê¦ÐÕÃû£ºÑô½àÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º331ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧËùÊôԺϵ£ºÒ©Ñ§ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÒ©ÀíѧÑо¿ÁìÓò£ºÖ×ÁöÒ©ÀíѧÑо¿ÁìÓò£ºÖ×ÁöÒ©Àíѧ[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºyanglz2005@126.com¸öÈ˼òÊö:Ñô½à£¬Å®£¬ºº×壬1978ÄêÉú£¬¼®¹á¹ðÁÖ£¬Öй²µ³Ô±£¬Ò½Ñ§²©Ê¿¡¢½ÌÊÚ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27¹ãÎ÷Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÂÞСÁá
µ¼Ê¦ÐÕÃû£ºÂÞСÁáÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º330ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧËùÊôԺϵ£º¹ú¼ÒÉúÎï°ÐÏòÕïÖιú¼ÊÁªºÏÖÐÐÄ¡¢»ù´¡Ò½Ñ§Ôº¡¢Ö×ÁöҽѧԺְ³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÖ×Áöѧ¡¢ÃâÒßѧ¡¢Ò½Ñ§ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧÑо¿ÁìÓò£ºÖ×ÁöÃâÒß¡¢ÉúÎïÖÎÁÆÑо¿£¬¸Î°©±êÖ¾Îïɸѡ¼°¹¦ÄÜÑо¿Ñо¿ÁìÓò£ºÖ×ÁöÃâÒß¡¢ÉúÎïÖÎÁÆÑо¿£¬¸Î°© ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27¹ãÎ÷Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÀÍɽ
µ¼Ê¦ÐÕÃû£ºÀÍɽÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º325ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧËùÊôԺϵ£º¹ãÎ÷ÉúÎïÒ½Ò©Ðͬ´´ÐÂÖÐÐÄ¡¢µÚÒ»ÁÙ´²Ò½Ñ§ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÍâ¿ÆÑ§¡¢Íâ¿ÆÑ§(öλÔÓéÀֵǼÈë¿ÚÏÂÔØÐÍ)¸öÈ˼òÊö:ÀÍɽ£¬Öйú¹²²úµ³µ³Ô±¡£ÓÚ2000Äê6ÔÂ˶ʿÑо¿Éú±ÏÒµÓÚ¹ãÎ÷Ò½¿Æ´óѧÍâ¿Æ¹Ç¿ÆöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬2002Äê¹¥¶Á±±¾©´óѧ²©Ê¿Ñ§Î»£¬Ê¦´ÓÖйúÖø ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27¹ãÎ÷Ãñ×å´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÕÅÕðÓ¢
µ¼Ê¦ÐÕÃû£ºÕÅÕðÓ¢ÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º324ËùÊôԺУ£º¹ãÎ÷Ãñ×å´óѧËùÊôԺϵ£ºÎÄѧԺְ³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÖйú¹Å´úÎÄѧͨѶ·½Ê½:µç×ÓÓʼþ£º**@qq.com¸öÈ˼òÊö:2004Äê¶ÈÈ«Çøµ³Î¯ÕþÑÐϵͳÏȽø¹¤×÷ÕßÖй²¹ãÎ÷׳×å×ÔÖÎÇøÎ¯Ô±»áÕþ²ßÑо¿ÊÒ2005Äê2Ô£»2004Äê¶ÈÈ«Çøµ÷ÑÐÓßÇéÐÅÏ¢¹¤×÷ÏȽø¸öÈË ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27¹ãÎ÷Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-¬СÁá
µ¼Ê¦ÐÕÃû£ºÂ¬Ð¡ÁáÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º319ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧËùÊôԺϵ£º¹ú¼ÒÉúÎï°ÐÏòÕïÖιú¼ÊÁªºÏÖÐÐÄ¡¢»ù´¡Ò½Ñ§Ôº¡¢¿ÚǻҽѧԺְ³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º¿ÚÇ»ÁÙ´²Ò½Ñ§¡¢ÃâÒßѧ¡¢ÁÙ´²¿ÚǻҽѧÑо¿ÁìÓò£ºÖ×ÁöÉúÎï°ÐÏòÕï¶ÏºÍÖÎÁÆÑо¿ÁìÓò£ºÖ×ÁöÉúÎï°ÐÏòÕï¶ÏºÍÖÎÁÆ[ÊÕÆð]ͨѶ·½Ê½:°ì¹«µç»°£º**µç×ÓÓÊ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27¹ãÎ÷Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÔøÖ¾Óð
µ¼Ê¦ÐÕÃû£ºÔøÖ¾ÓðÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º318ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ò½Ñ§Ôº¡¢ÐÅÏ¢Óë¹ÜÀíѧԺְ³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÄÚ¿ÆÑ§¡¢ÀÏÄêҽѧ¡¢Éç»áҽѧÓëÎÀÉúÊÂÒµ¹ÜÀí¡¢ÄÚ¿ÆÑ§(öλÔÓéÀֵǼÈë¿ÚÏÂÔØÐÍ)¸öÈ˼òÊö:ÔøÖ¾Ó𣬽ÌÊÚ/Ö÷ÈÎҽʦ£¬¹ãÎ÷Ò½¿Æ´óѧµÚÒ»ÁÙ´²Ò½Ñ§Ôº¡¢µÚÒ»¸½ÊôÒ½ÔºÔº³¤¡¢µ³Î¯¸±Êé¼Ç£¬ÀÏÄ겡ѧ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27¹ãÎ÷Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÁõæÂæÂ
µ¼Ê¦ÐÕÃû£ºÁõæÂæÂÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º313ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧËùÊôԺϵ£º¹ãÎ÷ÉúÎïÒ½Ò©Ðͬ´´ÐÂÖÐÐÄ¡¢»ù´¡Ò½Ñ§ÔºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÏ¸°ûÉúÎïѧ¡¢ÔÙÉúҽѧÑо¿ÁìÓò£ºÖÐÊàÉñ¾ÏµÍ³·¢Óý¡¢Éñ¾¸Éϸ°û¡¢Éñ¾ÔÙÉú¼°·¢ÓýÏà¹ØÐÔÖØ´ó¼²²¡µÄ¹Ø¼ü·Ö×Óϸ°ûµ÷¿Ø»úÀíºÍµçÉúÀí»ú...[Õ¹¿ª]Ñо¿ÁìÓò£ºÖÐÊàÉñ¾ÏµÍ³ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27¹ãÎ÷Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÑÏÁÖº£
µ¼Ê¦ÐÕÃû£ºÑÏÁÖº£ÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º312ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧËùÊôԺϵ£ºÖ×ÁöҽѧԺְ³Æ£º×¡ÔºÒ½Ê¦µ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÖ×ÁöѧÑо¿ÁìÓò£ºÎ¸³¦µÀÖ×Áö·¢Éú¼°ÖÎÁƵĻúÖÆÑо¿Ñо¿ÁìÓò£ºÎ¸³¦µÀÖ×Áö·¢Éú¼°ÖÎÁƵĻúÖÆÑо¿[ÊÕÆð]¸öÈ˼òÊö:ÑÏÁÖº££¬ÄУ¬1984.07£¬²©Ê¿£¬¾ÍÖ°ÓÚ¹ãÎ÷Ò½¿Æ´óѧÖ×ÁöҽԺ賦Íâ¿Æ£¬Ò½Ê¦ÁÙ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27¹ãÎ÷Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÇØÑ©
µ¼Ê¦ÐÕÃû£ºÇØÑ©ÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º313ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧËùÊôԺϵ£º¹ãÎ÷ÉúÎïÒ½Ò©Ðͬ´´ÐÂÖÐÐÄ¡¢µÚÒ»ÁÙ´²Ò½Ñ§ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÁÙ´²¼ìÑéÕï¶Ïѧ¡¢ÔÙÉúҽѧ¡¢ÁÙ´²¼ìÑéÕï¶Ïѧ(öλÔÓéÀֵǼÈë¿ÚÏÂÔØÐÍ)Ñо¿ÁìÓò£º¸ÎÔ༲²¡µ°°×ÖÊ×éѧ¡¢¸ÎÔà΢»·¾³ÖÐÖ×ÁöÏà¹Ø¾ÞÊÉϸ°ûÍâ·ÖÃÚµ°°×µÄ²îÒì±í´ï¼°Æä¹¦ÄÜÑо¿Ñо¿ÁìÓò£º ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27¹ãÎ÷Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ËÕÇ¿
µ¼Ê¦ÐÕÃû£ºËÕÇ¿ÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º311ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ò½Ñ§ÔºÖ°³Æ£ºÖ÷ÖÎҽʦµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÄÚ¿ÆÑ§Ñо¿ÁìÓò£º1.·Ç±àÂëºËËᣨnon-codingRNAs/miRNAs)ÔÚȱѪÐÔÐÄÔಡÖеÄ×÷Óü°»úÖÆÑÐ...[Õ¹¿ª]Ñо¿ÁìÓò£º1.·Ç±àÂëºËËᣨnon-codingRNAs/m ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
